Median overall survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Esophagogastric Junction Urothelium

Diseases78

Neoplasm Recurrence, Local Neoplasm Metastasis Lung Neoplasms Adenocarcinoma Disease Progression Brain Neoplasms Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Liver Neoplasms Breast Neoplasms Multiple Myeloma Recurrence Pancreatic Neoplasms Biliary Tract Neoplasms Neutropenia Carcinoma, Squamous Cell Stomach Neoplasms Melanoma Glioblastoma Ovarian Neoplasms Lymphatic Metastasis Central Nervous System Neoplasms Kidney Neoplasms Carcinoma Carcinoma, Renal Cell Leukemia, Myeloid, Acute Esophageal Neoplasms Bone Neoplasms Head and Neck Neoplasms Pleural Neoplasms Carcinoma, Hepatocellular Leukopenia Sarcoma Peritoneal Neoplasms Lymphoma, Non-Hodgkin Skin Neoplasms Mesothelioma Small Cell Lung Carcinoma Glioma Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell Myelodysplastic Syndromes Carcinoma, Small Cell Thrombocytopenia Neoplasms, Glandular and Epithelial Prostatic Neoplasms Nasopharyngeal Neoplasms Neoplasm Invasiveness Soft Tissue Neoplasms Drug Eruptions Hematologic Diseases Carcinoma, Adenosquamous Cholangiocarcinoma Nausea Carcinoma, Transitional Cell Carcinoma, Large Cell Urinary Bladder Neoplasms Neuroendocrine Tumors Leukemia, Lymphocytic, Chronic, B-Cell Neoplasms, Unknown Primary Gallbladder Neoplasms Stomatitis Adenocarcinoma, Mucinous Adenocarcinoma, Clear Cell Gastrointestinal Neoplasms Fatigue Bile Duct Neoplasms Gastrointestinal Stromal Tumors Diarrhea Lymphoma, B-Cell Urologic Neoplasms Anorexia Exanthema Drug-Related Side Effects and Adverse Reactions Neoplasms Lymphoma Hodgkin Disease Waldenstrom Macroglobulinemia

Chemicals and Drugs76

Deoxycytidine Fluorouracil Antineoplastic Agents Cisplatin Organoplatinum Compounds Taxoids Antibodies, Monoclonal, Humanized Leucovorin Camptothecin Paclitaxel Carboplatin Dacarbazine Doxorubicin Antimetabolites, Antineoplastic Antineoplastic Agents, Alkylating Vinblastine Cyclophosphamide Vincristine Tumor Markers, Biological Phenylurea Compounds Niacinamide Benzenesulfonates Quinazolines Etoposide Antibodies, Monoclonal Thalidomide Melphalan Prednisone Anthracyclines Cytarabine Antineoplastic Agents, Phytogenic Platinum Compounds Epirubicin Ifosfamide Methotrexate Bridged Compounds Angiogenesis Inhibitors Protein Kinase Inhibitors Platinum Tegafur Oxonic Acid Dexamethasone Lomustine Antibodies, Monoclonal, Murine-Derived Receptor, Epidermal Growth Factor Boronic Acids Guanine Pyrazines Mitoxantrone Pyrroles Glutamates Pyridines Receptor, erbB-2 Estramustine Antineoplastic Agents, Hormonal Interferon-alpha Vidarabine Antibiotics, Antineoplastic Benzamides Arabinonucleosides Carmustine Pyrimidines Indoles Myeloablative Agonists Thiotepa Topotecan Daunorubicin Epothilones Mitomycin Piperazines Isotretinoin Granulocyte Colony-Stimulating Factor Prostate-Specific Antigen ras Proteins Azacitidine Cancer Vaccines

Analytical, Diagnostic and Therapeutic Techniques and Equipment80

Survival Rate Disease-Free Survival Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Survival Analysis Kaplan-Meier Estimate Prognosis Neoplasm Staging Retrospective Studies Combined Modality Therapy Drug Administration Schedule Follow-Up Studies Salvage Therapy Chemotherapy, Adjuvant Proportional Hazards Models Remission Induction Infusions, Intravenous Multivariate Analysis Prospective Studies Chemoradiotherapy Radiotherapy, Adjuvant Neoadjuvant Therapy Transplantation, Autologous Maximum Tolerated Dose Induction Chemotherapy Treatment Failure Radiotherapy Dosage Cohort Studies Immunohistochemistry Karnofsky Performance Status Neoplasm Grading Hematopoietic Stem Cell Transplantation Dose Fractionation Radiotherapy Clinical Trials, Phase III as Topic Palliative Care Predictive Value of Tests Retreatment Risk Factors Administration, Oral Compassionate Use Trials Radiosurgery Risk Assessment Feasibility Studies Consolidation Chemotherapy Cranial Irradiation Randomized Controlled Trials as Topic Transplantation, Homologous Clinical Trials, Phase II as Topic Chemoembolization, Therapeutic Life Tables Chemotherapy, Cancer, Regional Perfusion Early Termination of Clinical Trials Transplantation Conditioning Clinical Trials as Topic Clinical Trials, Phase I as Topic Hepatectomy Probability Stem Cell Transplantation Tumor Burden Infusions, Intra-Arterial Chi-Square Distribution Peripheral Blood Stem Cell Transplantation Statistics, Nonparametric Registries Patient Selection Pilot Projects Pneumonectomy Hyperthermia, Induced Chemoradiotherapy, Adjuvant Immunoenzyme Techniques In Situ Hybridization, Fluorescence Incidence Positron-Emission Tomography Confidence Intervals Immunotherapy Orchiectomy Analysis of Variance Injections, Intravenous Tomography, X-Ray Computed

Phenomena and Processes11

Cell Survival Time Factors Drug Resistance, Neoplasm Maximum Tolerated Dose Dose-Response Relationship, Drug Graft Survival Mutation Probability Chi-Square Distribution Gene Expression Regulation, Neoplastic Genes, erbB-1

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Life Tables Registries Incidence

Health Care36

Survival Rate Disease-Free Survival Treatment Outcome Survival Analysis Kaplan-Meier Estimate Retrospective Studies Follow-Up Studies Proportional Hazards Models Multivariate Analysis Prospective Studies Treatment Failure Cohort Studies Karnofsky Performance Status Clinical Trials, Phase III as Topic Palliative Care Predictive Value of Tests Risk Factors Risk Assessment Feasibility Studies Randomized Controlled Trials as Topic Age Factors Clinical Trials, Phase II as Topic Life Tables Early Termination of Clinical Trials Clinical Trials as Topic Clinical Trials, Phase I as Topic Probability Chi-Square Distribution International Agencies Statistics, Nonparametric Registries Patient Selection Pilot Projects Incidence Confidence Intervals Analysis of Variance

Geographicals3

France Japan Germany

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Survival Rate Disease-Free Survival Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Survival Analysis Kaplan-Meier Estimate Prognosis Neoplasm Staging Deoxycytidine Retrospective Studies Fluorouracil Combined Modality Therapy Drug Administration Schedule Neoplasm Recurrence, Local Antineoplastic Agents Cisplatin Neoplasm Metastasis Organoplatinum Compounds Follow-Up Studies Salvage Therapy Lung Neoplasms Taxoids Adenocarcinoma Disease Progression Antibodies, Monoclonal, Humanized Leucovorin Cell Survival Camptothecin Brain Neoplasms Paclitaxel Chemotherapy, Adjuvant Carboplatin Survival Dacarbazine Proportional Hazards Models Time Factors Carcinoma, Non-Small-Cell Lung Doxorubicin Remission Induction Colorectal Neoplasms Infusions, Intravenous Antimetabolites, Antineoplastic Liver Neoplasms Antineoplastic Agents, Alkylating Multivariate Analysis Vinblastine Breast Neoplasms Cyclophosphamide Vincristine Tumor Markers, Biological Phenylurea Compounds Niacinamide Multiple Myeloma Benzenesulfonates Recurrence Prospective Studies Chemoradiotherapy Pancreatic Neoplasms Biliary Tract Neoplasms Quinazolines Neutropenia Radiotherapy, Adjuvant Etoposide Neoadjuvant Therapy Carcinoma, Squamous Cell Stomach Neoplasms Antibodies, Monoclonal Melanoma Thalidomide Melphalan Glioblastoma Drug Resistance, Neoplasm Prednisone Ovarian Neoplasms Transplantation, Autologous Lymphatic Metastasis Anthracyclines Maximum Tolerated Dose Central Nervous System Neoplasms Kidney Neoplasms Cytarabine Carcinoma Antineoplastic Agents, Phytogenic Induction Chemotherapy Carcinoma, Renal Cell Treatment Failure Leukemia, Myeloid, Acute Radiotherapy Dosage Esophageal Neoplasms Platinum Compounds Cohort Studies Immunohistochemistry Epirubicin Bone Neoplasms Karnofsky Performance Status Head and Neck Neoplasms Neoplasm Grading Pleural Neoplasms Dose-Response Relationship, Drug Carcinoma, Hepatocellular

No FAQ available that match "median overall survival"